← Back to Search

Procedure

tDCS for Chronic Pain (tDCS-pain Trial)

N/A

Waitlist Available

Led By Guillume Léonard

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be aged ≥ 65 years

Have chronic (≥ 6 months) musculoskeletal pain of moderate to severe intensity (≥4 out of 10 on a numerical scale of 0 to 10)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up i. 1 week before the intervention

Awards & highlights

tDCS-pain Trial Summary

This trial will test if real tDCS can help reduce pain in elderly people with chronic moderate-severe pain. Participants, assessors, and tDCS providers will be blinded in the study.

Who is the study for?

This trial is for seniors aged 65 or older with chronic musculoskeletal pain lasting over 6 months and rated at least moderate in severity. It's not suitable for those with conditions that make tDCS unsafe, like certain contraindications to tDCS, TMS, IRM, or if a health professional thinks the study might harm them. People on medications affecting GABAergic and glutamatergic systems are also excluded.Check my eligibility

What is being tested?

The study tests whether actual transcranial direct current stimulation (tDCS) can reduce chronic pain in older adults compared to a placebo version of the same treatment. Participants will be randomly assigned to receive either real or sham tDCS daily for five days and followed up after one week and three months.See study design

What are the potential side effects?

While specific side effects aren't listed here, typical ones from tDCS may include mild tingling, itching or discomfort at the electrode site during application. Serious side effects are rare but could involve headaches or nausea.

tDCS-pain Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

I have had pain in my muscles or bones for over 6 months, rated at least 4 out of 10.

tDCS-pain Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ mean of patient reported pain on 5 consecutive days: i. 1 week before the intervention compared to1 week after the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~mean of patient reported pain on 5 consecutive days: i. 1 week before the intervention compared to1 week after the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and mean of patient reported pain on 5 consecutive days: i. 1 week before the intervention compared to1 week after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain

Secondary outcome measures

Change in affective component of pain from baseline to 1 week and 3 months after intervention

Change in mood from baseline to 1 week and 3 months after intervention

Change in perception of change with treatment from 1 week to 3 months after intervention

+5 more

tDCS-pain Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: actual tDCSExperimental Treatment1 Intervention

The actual transcranial direct current stimulation (tDCS) intervention will be conducted by a physiotherapist who will perform 5 sessions of actual tDCS , 5 consecutive days, for 20 minutes of treatment for a total of 45 minutes at the clinic for each session. The tDCS current will be 2 mA for the whole 20-minute session.

Group II: placebo tDCSPlacebo Group1 Intervention

The placebo transcranial direct current stimulation (tDCS) intervention will be conducted by a physiotherapist who will perform 5 sessions of placebo tDCS, 5 consecutive days, for 20 minutes of treatment for a total of 45 minutes at the clinic for each session. The tDCS current will be 2 mA for 30 secondes, and then will strop for the rest of the 20-minute session (programming of the equipment).

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor

292 Previous Clinical Trials

69,291 Total Patients Enrolled

11 Trials studying Chronic Pain

998 Patients Enrolled for Chronic Pain

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,340 Previous Clinical Trials

26,452,548 Total Patients Enrolled

10 Trials studying Chronic Pain

7,896 Patients Enrolled for Chronic Pain

Guillume LéonardPrincipal InvestigatorUniversité de Sherbrooke

Media Library

Transcranial Direct Current Stimulation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05617027 — N/A

Chronic Pain Research Study Groups: actual tDCS, placebo tDCS

Chronic Pain Clinical Trial 2023: Transcranial Direct Current Stimulation Highlights & Side Effects. Trial Name: NCT05617027 — N/A

Transcranial Direct Current Stimulation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05617027 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you explain the principal aims of this research?

"The primary goal of this clinical trial, measured by the mean patient reported pain on 5 consecutive days before and after intervention is to observe how long-lasting its effects are; from 1 week all the way up to 3 months. Additional objectives include evaluating changes in mood using Hospital Anxiety and Depression Scale, quality of life with SF-36 survey, as well as Patient Global Impression of Change assessment."

Answered by AI

Does this clinical experiment have any open slots for volunteers?

"This clinical trial, posted on December 1st 2022 and last updated November 8th of the same year, is no longer seeking applicants. However, 403 other trials are currently open for recruitment across multiple sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Relieving Chronic Pain in Older Adults With Transcranial Direct Current Stimulation

2023. "Relieving Chronic Pain in Older Adults With Transcranial Direct Current Stimulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05617027.

All > Tdcs